Swiss National Bank Chimerix Inc Transaction History

Swiss National Bank

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	BUY	$1.34 - $5.34 $26,532 - $105,732	19,800 Added 11.34%	194,400 $404,000
Q1 2022 May 09, 2022	BUY	$4.58 - $6.8 $64,578 - $95,880	14,100 Added 8.79%	174,600 $800,000
Q2 2021 Aug 06, 2021	BUY	$7.54 - $9.79 $1.21 Million - $1.57 Million	160,500 New	160,500 $1.28 Million
Q4 2017 Feb 07, 2018	SELL	$4.32 - $5.52 $284,256 - $363,216	-65,800 Closed	0 $0
Q3 2017 Nov 03, 2017	BUY	$4.35 - $5.25 $286,230 - $345,450	65,800	65,800 $345,000

36.8M

72.2K

169K

Ticker CMRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,622,896
Market Cap $85M
Description
Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

Stay updated on Swiss National Bank with notifications on news.